These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15312991)
1. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? Youan BB J Control Release; 2004 Aug; 98(3):337-53. PubMed ID: 15312991 [TBL] [Abstract][Full Text] [Related]
2. Drug delivery system based on chronobiology--A review. Mandal AS; Biswas N; Karim KM; Guha A; Chatterjee S; Behera M; Kuotsu K J Control Release; 2010 Nov; 147(3):314-25. PubMed ID: 20691738 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Chronopharmaceuticals: hype or future of pharmaceutics. Philip AK; Philip B Curr Pharm Des; 2011; 17(15):1512-6. PubMed ID: 21501113 [TBL] [Abstract][Full Text] [Related]
5. Chronopharmaceutics: as a clinically relevant drug delivery system. Gandhi BR; Mundada AS; Gandhi PP Drug Deliv; 2011 Jan; 18(1):1-18. PubMed ID: 21138394 [TBL] [Abstract][Full Text] [Related]
6. Mathematical modeling of drug delivery. Siepmann J; Siepmann F Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362 [TBL] [Abstract][Full Text] [Related]
7. Chronopharmaceutics based modern colon specific drug delivery systems. Tiwari A; Shukla RK; Tiwari S; Naazneen S Curr Drug Discov Technol; 2012 Dec; 9(4):311-8. PubMed ID: 22564168 [TBL] [Abstract][Full Text] [Related]
8. Emerging applications of kinetic biomarkers in preclinical and clinical drug development. Turner SM; Hellerstein MK Curr Opin Drug Discov Devel; 2005 Jan; 8(1):115-26. PubMed ID: 15679179 [TBL] [Abstract][Full Text] [Related]
9. In vitro - in vivo correlation: from theory to applications. Emami J J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187 [TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticles--properties and prospects for their use in human medicine. Sanvicens N; Marco MP Trends Biotechnol; 2008 Aug; 26(8):425-33. PubMed ID: 18514941 [TBL] [Abstract][Full Text] [Related]
14. Vaccine presentations and delivery technologies--what does the future hold? Clements CJ; Wesselingh SL Expert Rev Vaccines; 2005 Jun; 4(3):281-7. PubMed ID: 16026244 [TBL] [Abstract][Full Text] [Related]
15. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. Dahan A; Hoffman A J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294 [TBL] [Abstract][Full Text] [Related]
16. Hydrogels in controlled release formulations: network design and mathematical modeling. Lin CC; Metters AT Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1379-408. PubMed ID: 17081649 [TBL] [Abstract][Full Text] [Related]
17. Molecularly imprinted materials as advanced excipients for drug delivery systems. Alvarez-Lorenzo C; Concheiro A Biotechnol Annu Rev; 2006; 12():225-68. PubMed ID: 17045196 [TBL] [Abstract][Full Text] [Related]
18. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. Roy P; Shahiwala A J Control Release; 2009 Mar; 134(2):74-80. PubMed ID: 19105973 [TBL] [Abstract][Full Text] [Related]
20. Current status and approaches to developing press-coated chronodelivery drug systems. Lin SY; Kawashima Y J Control Release; 2012 Feb; 157(3):331-53. PubMed ID: 21968338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]